NEW YORK CITY, NY / ACCESS Newswire / October 14, 2025 / NEW YORK, NY / ACCESS Newswire / October 14, 2025 / If you suffered a loss on your Tronox Holdings plc (NYSE:TROX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: […]
Reports 16.3% EBIT margin, 43.7% Y-o-Y growth Persistent Systems (BSE: 533179) and (NSE: PERSISTENT) today announced the Company's audited financial results for the quarter ended September 30, 2025, as approved by the Board of Directors. https://mma.prnewswire.com/media/1022385/4851381/Persistent_Systems_Logo.jpg Consolidated Financial Highlights for the Quarter ended September 30, 2025: Q2FY26 Margin % Q-o-Q Growth Y-o-Y GrowthRevenue(USD Million) 406.2
NEW YORK CITY, NY / ACCESS Newswire / October 14, 2025 / WHY: New York, N.Y., October 14, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Unicycive Therapeutics, Inc. (NASDAQ:UNCY) between March 29, 2024 and June 27, 2025, both dates inclusive (the "Class Period"), of the important October
NEW YORK CITY, NY / ACCESS Newswire / October 14, 2025 / NEW YORK, NY / ACCESS Newswire / October 14, 2025 / If you suffered a loss on your KBR, Inc. (NYSE:KBR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/kbr-inc-lawsuit-submission-form?prid=172256&wire=1&utm_campaign=25
NEW YORK CITY, NY / ACCESS Newswire / October 14, 2025 / NEW YORK, NY / ACCESS Newswire / October 14, 2025 / If you suffered a loss on your Cytokinetics, Incorporated (NASDAQ:CYTK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cytokinetics-incorporated-lawsuit-submission-form-2?prid=172254&wire=1&utm_campaign=4
New CEO, CFO, and EVP of Life Science named to drive strategic execution across Diagnostics and Life Science. Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced executive appointments aimed at strengthening global operations and accelerating strategic growth across Diagnostics and Life Science. https://mma.prnewswire.com/media/1655279/Meridian_Bioscience_Logo.jpg Andy Kitzmiller Appointed
NEW YORK CITY, NY / ACCESS Newswire / October 14, 2025 / NEW YORK, NY / ACCESS Newswire / October 14, 2025 / If you suffered a loss on your Dow Inc. (NYSE:DOW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/dow-inc-lawsuit-submission-form?prid=172255&wire=1&utm_campaign=3
The correctional healthcare industry has long faced scrutiny, grappling with the unique challenges of providing quality medical care within a custodial environment. However, a recent groundbreaking Harvard study sheds light on a powerful advantage: accreditation. This research provides compelling evidence that adherence to recognized standards significantly improves patient safety and drastically reduces mortality rates in
(NasdaqGM:PDLB), NEW YORK, Oct. 14, 2025 (GLOBE NEWSWIRE) — Ponce Financial Group, Inc. (the “Company”) announces that effective October 10, 2025, its wholly-owned subsidiary, Ponce Bank (formerly a federally chartered stock savings association), has completed its previously announced conversion to a national bank and commenced operations as Ponce Bank, National Association (the “Bank”). In connection
Ponce Financial Group announces that Ponce Bank has commenced operations as Ponce Bank, National Association GlobeNewswire October 14, 2025 NEW YORK, Oct. 14, 2025 (GLOBE NEWSWIRE) — Ponce Financial Group, Inc. (the “Company”) announces that effective October 10, 2025, its wholly-owned subsidiary, Ponce Bank (formerly a federally chartered stock savings association), has completed its previously